0001362118-23-000036.txt : 20230607
0001362118-23-000036.hdr.sgml : 20230607
20230607172701
ACCESSION NUMBER: 0001362118-23-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230605
FILED AS OF DATE: 20230607
DATE AS OF CHANGE: 20230607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Velge Bertrand
CENTRAL INDEX KEY: 0001758339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 23999973
MAIL ADDRESS:
STREET 1: BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND
STREET 2: ROMNEY MARSH
CITY: KENT
STATE: X0
ZIP: TN299TR
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-05
0
0000948320
LifeMD, Inc.
LFMD
0001758339
Velge Bertrand
C/O LIFEMD, INC
236 FIFTH AVENUE, 4TH FLOOR
NEW YORK
NY
10001
1
0
0
0
0
Common Stock
2023-06-05
4
P
0
10383
2.1651
A
10383
I
By Mascot Capital Management, LLC
Common Stock
2023-06-06
4
P
0
129117
2.1794
A
139500
I
By Mascot Capital Management, LLC
Common Stock
916666
I
By Aliunde LLC
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.15 to $2.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
/s/ Bertrand Velge
2023-06-07